EuclidSR Partners is a venture capital firm which invests in life sciences, convergence and information technology. ESR is a $250 million venture partnership; the fifth since the founding of the original predecessor partnership, Euclid Partners, more than three decades ago. The partner's experience also encompasses two decades of corporate pharmaceutical venture investing through S.R. One, Limited.